EGFR and lung cancer: Furthermore, a sensitivity of 61% has been reported using MassARRAY to detect EGFR mutations in plasma ctDNA from lung cancer patients [21], while the SABER/MassARRAY method has been successfully used to detect the T790M EGFR mutation in EGFR-TKI refractory lung cancer patients [15].